Financial Year |
March 31 2023 |
Monetary Funds |
554,020,013.64 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
102,691,307.11 |
Accounts Receivable |
295,298,685.50 |
Advances to Suppliers |
15,623,663.09 |
Other Receivables |
2,461,530.65 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
507,735,979.77 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
10,404,464.81 |
Total Current Assets |
1,499,592,438.52 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
30,978,061.65 |
Investment Properties |
-- |
Fixed Assetes |
585,117,034.00 |
Under-construction Projects |
190,489,102.87 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
253,720,767.11 |
R&D expenses |
39,528,329.22 |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
2,794,854.50 |
Deferred Income Tax Assets |
28,051,659.91 |
Other Non-Current Assets |
58,628,903.55 |
Sub-Total of Non-Current Assets |
1,276,905,911.77 |
Total Assets |
2,776,498,350.29 |
Short-Term Loans |
70,000,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
86,051,979.30 |
Accounts Payable |
144,091,402.96 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
25,177,728.33 |
Taxes Payable |
9,320,062.97 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
39,443,121.91 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
2,069,333.33 |
Other Current Liabilities |
61,840,455.01 |
Sub-Total of Current Liabilities |
455,061,859.53 |
Long-term Loans |
76,000,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
5,171,794.65 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
201,889,080.00 |
Total Liabilities |
656,950,939.53 |
Paid-In Capital(Or Share Stock) |
573,104,819.00 |
Capital Surplus |
1,678,361,693.07 |
Surplus Reserve |
19,940,955.96 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-185,976,884.86 |
Minority Stockholder's Interest |
23,031,786.93 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,096,515,623.83 |
Owner's Equity(Stockholder's Equity) |
2,119,547,410.76 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,776,498,350.29 |